Currency in USD
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2025) | Next year (2026) |
---|
No. of analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 0.04 | 0.03 | 0.12 | 0.2 |
Low estimate | -0.01 | -0.01 | -0.03 | -0.02 |
High estimate | 0.11 | 0.08 | 0.33 | 0.4 |
Year ago EPS | 0.03 | -0.05 | -0.01 | 0.12 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2025) | Next year (2026) |
---|
No. of analysts | 5 | 4 | 5 | 3 |
Avg. Estimate | 26.84M | 26.05M | 104.77M | 105.99M |
Low estimate | 25.8M | 25M | 99.3M | 94.52M |
High estimate | 28.5M | 27M | 112M | 114.24M |
Year ago sales | 29.35M | N/A | 113.05M | 104.77M |
Sales growth (year/est) | -8.60% | N/A | -7.30% | 1.20% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|
Est. EPS | -0.01 | 0.02 | 0.03 | -0.02 |
Actual EPS | 0.03 | -0.05 | -0.02 | 0.03 |
Difference | 0.04 | -0.07 | -0.05 | 0.05 |
Surprise % | 400.00% | -350.00% | -166.70% | 250.00% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2025) | Next year (2026) |
---|
Current estimate | 0.04 | 0.03 | 0.12 | 0.2 |
7 days ago | 0.04 | 0.03 | 0.12 | 0.2 |
30 days ago | -0.02 | -0.02 | -0.01 | -0.01 |
60 days ago | -0.03 | -0.02 | 0.07 | 0.13 |
90 days ago | -0.03 | -0.02 | 0.07 | 0.13 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2025) | Next year (2026) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | MEDXF | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 33.30% | N/A | N/A | N/A |
Next qtr. | 160.00% | N/A | N/A | N/A |
Current year | 1,300.00% | N/A | N/A | N/A |
Next year | 66.70% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |